Streetbeat News

Price Targets

HLMN

Barclays analyst Matthew Bouley maintains an Overweight rating on Hillman Solns (NASDAQ:HLMN) but has lowered the price target from $11 to $10.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 6:22 pm

GMED

Barclays analyst Matt Miksic maintains an Overweight rating on Globus Medical (NYSE:GMED) and raises the price target from $77 to $86.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 6:20 pm

FBIN

Barclays analyst Matthew Bouley maintains an Overweight rating on Fortune Brands (NYSE:FBIN) but has lowered the price target from $89 to $74.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 6:19 pm

JKHY

Goldman Sachs has downgraded Jack Henry & Associates from Neutral to Sell and set a price target of $140. This has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 6:17 pm

FND

Barclays analyst Seth Sigman has maintained an 'Underweight' rating on Floor & Decor Holdings (NYSE:FND) and lowered the price target from $88 to $80.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 6:16 pm

RMD

ResMed's stock has been downgraded from Outperform to Sector Perform by RBC Capital, which also lowered its price target from $273 to $202. This has resulted in ResMed shares trading lower.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 6:14 pm

ORA

Oppenheimer analyst Noah Kaye has maintained an 'Outperform' rating on Ormat Technologies (NYSE:ORA) but lowered the price target from $96 to $84.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 6:12 pm

CWEN

Oppenheimer analyst Noah Kaye maintains an Outperform rating on Clearway Energy (NYSE:CWEN) but has lowered the price target from $38 to $34.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 6:11 pm

ENR

Barclays analyst Lauren Lieberman maintains an Overweight rating on Energizer Holdings (ENR) but has lowered the price target from $40 to $34.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 6:11 pm

AMRC

Oppenheimer analyst Noah Kaye has maintained an 'Outperform' rating on Ameresco (NYSE:AMRC), but lowered the price target from $67 to $55.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 6:09 pm